President Donald Trump is debating on reclassifying marijuana as a less dangerous drug, Josh Dawsey of The Wall Street Journal reports, citing people familiar with the matter. Earlier this month, Trump said he was interested in change, the sources added. Such a shift would make it easier to buy and sell pot. Publicly traded companies in the space include Aurora Cannabis (ACB), CV Sciences (CVSI), Canopy Growth (CGC), Cronos Group (CRON), Goodness Growth (GDNSF), Green Thumb Industries (GTBIF), IGC Pharma (IGC), Tilray (TLRY), Trees Corporation (CANN) and Trulieve Cannabis (TCNNF).
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACB:
- Aurora Cannabis Announces 2025 AGM Results and Board Changes
- Aurora Cannabis Reports Strong Q1 2026 Results
- Aurora Cannabis Shines in Earnings Call Despite Challenges
- Aurora Cannabis Reports Strong Q1 2026 Results with Significant Growth in Medical Cannabis Revenue
- Aurora Cannabis Reports Revenue Growth in Latest Financial Update